Clinical Trial Update: Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial completed evaluating the safety and efficacy of long-acting repeatable octreotide acetate injectable suspension versus surgery in treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Long-acting Repeatable Octreotide Acetate for Injectable Suspension (octreotide acetate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acromegaly | Phase 3 | Status: COMPLETED